Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Just Published: Empirical Study Examining Public Preferences Regarding End of Life Treatments
24 November 2014
Just published in Social Science & Medicine [open access] is a social preference study by OHE’s Koonal Shah and the University of Sheffield’s Aki Tsuchiya and Allan…
Implementing NICE Decisions in Wales: Opportunity Costs
10 June 2014
Just out is a new Research Paper from OHE that examines how local NHS organisations in Wales adjust spending to accommodate ‘shocks’ such as new NICE…
Social Preferences and Burden of Illness in Value-based Assessments
11 February 2014
This recent research is intended to inform changes in NICE’s approach to assessing the value of medical technologies. Throughout the year, OHE presents a number of…
OHE at HESG: Value-based Assessment in the UK; Developing the EQ-5D-5L
23 January 2014
OHE’s contributions focused on approaches to implementing UK value-based assessment and the details of creating an EQ-5D-5L value set for England. The Health Economists’ Study Group…
Opportunity Costs of Implementing NICE Decisions in NHS Wales
1 June 2014
This new research from the OHE examines how Local Health Boards (LHBs) in Wales adjust spending to meet the statutory requirement of providing access to technologies…
Can the US Afford to Ignore Cost-effectiveness Evidence?
1 March 2014
Cost-effectiveness analysis plays a limited role in US health care compared to many other countries. In this Seminar Briefing, Dr James Chambers, Center for the Evaluation…
Projecting Expenditure on Medicines in the NHS: Second Edition
1 January 2014
The Pharmaceutical Price Regulation Scheme (PPRS) 2014 Heads of Agreement, announced on 6 November 2013, outlines the terms of the five-year deal between the pharmaceuctical industry…
Inconsistent Use of Cost-effectiveness Thresholds in NHS Scotland
12 December 2013
This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards. OHE today released a Research Paper on the…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
A pilot study demonstrated the value of involving a range of stakeholders in MCDA for rare disease therapies. According to a study just published by the…